Fingerprint
Dive into the research topics of 'Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: A case series'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: A case series
Kapil D. Sethi, Robert A. Hauser, Stuart H. Isaacson, Terry McClain
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations